Protected: Vision-sparing targeted phototherapy for uveal melanoma
There is no excerpt because this is a protected post.
Protected: Vision-sparing targeted phototherapy for uveal melanoma Read More »
National Cancer Institute
Combining photoimmunotherapy with immune checkpoint inhibition
Motivation for the study The motivation was to study if photoimmunotherapy could enhance anti-tumor immunity when combined with immune checkpoint inhibition. CD44-targeted photoimmunotherapy was applied against poorly immunogenic, “cold” tumor and antitumor effect was studied alone and in combination with anti-PD-1 immune checkpoint inhibition. Sensitization of this “cold” tumor to immune checkpoint inhibition after photoimmunotherapy
Combining photoimmunotherapy with immune checkpoint inhibition Read More »
ML7710 for photoimmunotherapy against regulatory T cells in tumors
Results Tumor growth was significantly suppressed by photoimmunotherapy, compared to control or IgG without light activation. Tumor growth suppression, as well as overall survival after photoimmunotherapy, were significantly better with F(ab´)2 fragments than with full IgG. This efficacy improvement might be related to killer T cells, which were detected in much higher numbers
ML7710 for photoimmunotherapy against regulatory T cells in tumors Read More »
Novel antimicrobial phototherapy against emerging infectious diseases
Results PIAS-treated pathogens were effectively eradicated upon NIR illumination. The efficacy of PIAS was dependent on the NIR light dose, 50 J/cm2 eradicating all MRSA from the rat nasal tract (Figure 1). PIAS also saved all mice from fatal MRSA infections, similar to VCM+RFP antibiotics and even more effectively than VCM antibiotics
Novel antimicrobial phototherapy against emerging infectious diseases Read More »